Health brand consultancy company Arcadia Group has announced the launch of an Amazon exclusive brand of consumer-use medical devices for diabetes and hypertension management. The new Choice brand will start with a range of blood glucose monitors and blood pressure monitors both with supporting mobile apps which offer measurement tracking, data mobility and reminders.
It is estimated that diabetes and hypertension affect up to 130 million Americans. People afflicted with either of these chronic diseases can benefit from daily monitoring and progress tracking over time. Choice’s new offerings are designed to make health management more accessible, affordable and actionable.
The Choice brand will offer both conventional models and devices enabled with Bluetooth connectivity features. Arcadia has experience in brand development within the diabetes and cardiovascular markets. They have previously worked on Walmart’s ReliOn brand as well as Abbott’s Freestyle line of diabetes devices.
Bob Guest, CEO of Arcadia Group, commented, “The Choice brand is all about accessible wellness. Consumers no longer need to drive to a store to stand in-line and purchase their medical devices and supplies. Therefore, customers have the freedom of choice.”
Looking forward, Guest added, “Our products are best in class and very affordable. Over time we intend to incorporate voice driven measurement interpretation as well as individualise wellness recommendations. This is all possible with Alexa and will provide patients with a wellness experience not available until now.”